1. The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance
   Shulong Cao et al, 2021, Frontiers in Molecular Biosciences CrossRef
2. Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration
   Bowen Qing et al, 2023, Frontiers in Pharmacology CrossRef
3. Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors
   Milan Hano et al, 2018, Molecules CrossRef
4. Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway
   Rania Alaaeldin et al, 2021, Molecules CrossRef
5. Metabolic implications of organelle–mitochondria communication
   Isabel Gordaliza‐Alaguero et al, 2019, EMBO reports CrossRef
6. The Combination of Natural Molecules Naringenin, Hesperetin, Curcumin, Polydatin and Quercetin Synergistically Decreases SEMA3E Expression Levels and DPPIV Activity in In Vitro Models of Insulin Resistance
   Emanuele-Salvatore Scarpa et al, 2023, International Journal of Molecular Sciences CrossRef
7. miR-338-3p and miR-34a-5p act as antagonists in phycocyanin-mediated process of ameliorating glycometabolism in T2DM HepG2 cells
   Wenjing Zhang et al, 2024, Journal of Functional Foods CrossRef
8. Endoplasmic reticulum stress: Multiple regulatory roles in hepatocellular carcinoma
   Jiacheng Wu et al, 2021, Biomedicine & Pharmacotherapy CrossRef
9. Sex Hormone Binding Globulin (SHBG) Mitigates ER Stress in Hepatocytes In Vitro and Ex Vivo
   Katarzyna Kornicka-Garbowska et al, 2021, Cells CrossRef
10. Role of endoplasmic reticulum stress in hepatic glucose and lipid metabolism and therapeutic strategies for metabolic liver disease
    Wenxiang Zheng et al, 2022, International Immunopharmacology CrossRef
11. Long non‐coding RNA‐mediated modulation of endoplasmic reticulum stress under pathological conditions
    Yusuf Cem Çiftçi et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
12. Bibliometric analysis of endoplasmic reticulum stress in hepatocellular carcinoma: trends and future directions
    Yaping Zhang et al, 2024, Discover Oncology CrossRef
13. Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer
    Yi-Fan Dang et al, 2021, Journal of Drug Targeting CrossRef
14. Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance
    Miao Yu et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
15. iTRAQ-Based Proteome Profiling of Differentially Expressed Proteins in Insulin-Resistant Human Hepatocellular Carcinoma
    Jing Yan et al, 2022, Frontiers in Cell and Developmental Biology CrossRef